Retraction

Smad4 induces cell death in HO-8910 and SKOV3 ovarian carcinoma cell lines via PI3K-mTOR involvement

Citations (4)

4
Total Citations
1
Post-Retraction
(25.0%)
2
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
1 Within 1 year
0 After 2+ years
15 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
<scp>SMAD4</scp> inhibits glycolysis in ovarian cancer through <scp>PI3K</scp>/<scp>AKT</scp>/<scp>HK2</scp> signaling pathway by activating <scp>ARHGAP10</scp>
Kui Wu, Wei Gong, Huanmei Sun et al. (9 authors)
Cancer Reports Open Access
Published: Jan 2024
1 citation
15 days after retraction
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells
Marcos Quintela, David W. James, Agne Pociute et al. (18 authors)
Clinical Epigenetics Open Access
Published: Apr 2023
6 citations
262 days before retraction
PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer
Ping Gao, Jinglan Hao, Qianwen Xie et al. (11 authors)
Oncogene Open Access
Published: Apr 2022
16 citations
624 days before retraction
Related Records

This article has multiple records in the database due to different notices:

Record #51130
Jul 19, 2021
Correction
Quick Stats
Total Citations: 7
Years Since Retraction: 1.9 year
Open Access: Yes
Last Checked: Jul 24, 2025